|
| Mechanism and confirmatory study of Xuanfei Baidu Decoction on treating ARDS based on network pharmacology and molecular docking |
| Hits 314 Download times 150 Received:December 12, 2023 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1673-9043.2024.04.02 |
| Key Words
Xuanfei Baidu Decoction;acute respiratory distress syndrome;network pharmacology;ferroptosis |
| Author Name | Affiliation | E-mail | | HAO Ting | School of Chinese Materia Medica, Hong Kong Baptist University, Hong Kong 999077, China | | | MA Ying | School of Pharmacy, Tianjin Medical University, Tianjin 300070, China | | | JIAO Yang | Department of Pharmacy, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300193, China | | | SONG Youkun | Department of Clinical Laboratory, The Third Central Hospital of Tianjin, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China | | | LIU Shuye | Department of Clinical Laboratory, The Third Central Hospital of Tianjin, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China | | | ZHU Yu | Department of Clinical Laboratory, The Third Central Hospital of Tianjin, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China | zhuyutj@126.com |
|
| Abstract
|
| [Objective] Explored and confirmed the mechanism of Xuanfei Baidu Decoction on acute respiratory distress syndrome(ARDS) by network pharmacology and molecular docking. [Methods] The active components of mahuang,cangzhu,huoxiang,qinghao,huzhang,mabiancao,yiyiren,lugen,tinglizi,kuxingren,huajuhong and gancao in Xuanfei Baidu Decoction were collected and screened by TCMSP and active component-target network was constructed. Genecards,SwissTargetPrediction and Uniprot database was used to obtain the disease targets of ARDS and target proteins network was constructed,DAVID database was used to perform gene ontology(GO) and KEGG pathway enrichment analysis. Components and key targets were docked by Schrödinger software to verify the binding energy. In order to confirmed the result of network pharmacology,ARDS rat were constructed by lipopolysaccharides and continuously sponsored the stomach for 28 days by Xuanfei Baidu Decoction.The interleukin(IL)-2,IL-4,IL-6,IL-10 and tumor Necrsis Factor(TNF)-ɑ,Interfereon(IFN)-γ in alveolar lavage fluid,the Glutathione(GSH),Malondialdehyde(MDA),Superoxidismutase(SOD) and Glutathione Peroxidase 4(GPX4) in lung tissues were analyzed by flow cytometry and ELISA assay. [Results] There were 205 active components which quercetin,kaempferol, β-sitosterol,stigmasterol,luteolin,isorhamnetin,naringenin and glabridin were top 8 degree value components,107 Hub targets which Jun,IL-6,TP53,AKT1,ALB,VEGFA,STAT3,CASP3,IL-1β and PTGS2 were top 10 degree value targets in Xiaoxianxiong Decoction for ARDS treatment. Bioinformation analysis showed the signaling pathway of IL-7,TNF and Toll-like receptor was related to the treatment of ARDS by Xuanfei Baidu Decoction. There was a low binding energy between key active components and ferroptosis related protein such as PTGS2 by molecular docking. Xuanfei Baidu Decoction could revise the abnormal inflammatory factor in alveolar lavage fluid and oxidation-reduction disbalance in lung tissues which inducted by lipopolysaccharides in rat model. [Conclusion] The mechanism of Xuanfei Baidu Decoction treat ARDS was related with releasing the oxidative damage and apoptosis,regulating inflammation signaling pathway,reducing inflammatory recruitment and cytokines secretion,and ferroptosis inhibition may be play an important role. |
|
|
|
|
|
